In GC, increased expression of DNMT1 compared to para-cancerous and normal tissues has been reported at both the mRNA and protein levels, with DNMT1 upregulation being associated with GC risk and worse prognosis [5,118,119,120,121,122]. This evidence concerns the gene DNMT1 and gastric cancer.